PMC:7205724 / 0-187 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"tao:has_database_id","subj":"1","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":132,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":89,"end":113},"obj":"Chemical"},{"id":"T2","span":{"begin":153,"end":168},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":132,"end":147},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T1","span":{"begin":89,"end":106},"obj":"http://purl.obolibrary.org/obo/IDO_0000610"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":153,"end":168},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":30,"end":38},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":39},"obj":"Sentence"},{"id":"T2","span":{"begin":40,"end":114},"obj":"Sentence"},{"id":"T3","span":{"begin":115,"end":168},"obj":"Sentence"},{"id":"T4","span":{"begin":170,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"pubann:denotes","subj":"1","obj":"MESH:C000657245"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T0","span":{"begin":0,"end":7},"obj":"IN"},{"id":"T1","span":{"begin":8,"end":17},"obj":"NN"},{"id":"T2","span":{"begin":18,"end":26},"obj":"NN"},{"id":"T3","span":{"begin":27,"end":29},"obj":"IN"},{"id":"T4","span":{"begin":30,"end":38},"obj":"NN"},{"id":"T5","span":{"begin":38,"end":39},"obj":"-COLON-"},{"id":"T6","span":{"begin":40,"end":49},"obj":"NN"},{"id":"T7","span":{"begin":50,"end":53},"obj":"CC"},{"id":"T8","span":{"begin":54,"end":64},"obj":"NN"},{"id":"T9","span":{"begin":65,"end":68},"obj":"IN"},{"id":"T10","span":{"begin":69,"end":72},"obj":"DT"},{"id":"T11","span":{"begin":73,"end":76},"obj":"NN"},{"id":"T12","span":{"begin":77,"end":79},"obj":"IN"},{"id":"T13","span":{"begin":80,"end":88},"obj":"JJ"},{"id":"T14","span":{"begin":89,"end":106},"obj":"JJ"},{"id":"T15","span":{"begin":107,"end":113},"obj":"NNS"},{"id":"T16","span":{"begin":113,"end":114},"obj":"-COLON-"},{"id":"T17","span":{"begin":115,"end":130},"obj":"NNS"},{"id":"T18","span":{"begin":130,"end":131},"obj":"-COMMA-"},{"id":"T19","span":{"begin":132,"end":147},"obj":"NNS"},{"id":"T20","span":{"begin":147,"end":148},"obj":"-COMMA-"},{"id":"T21","span":{"begin":149,"end":152},"obj":"CC"},{"id":"T22","span":{"begin":153,"end":168},"obj":"NNS"},{"id":"T23","span":{"begin":170,"end":180},"obj":"NNS"},{"id":"T24","span":{"begin":181,"end":182},"obj":"IN"}],"relations":[{"id":"R0","pred":"arg2Of","subj":"T2","obj":"T0"},{"id":"R1","pred":"arg1Of","subj":"T2","obj":"T1"},{"id":"R2","pred":"arg1Of","subj":"T2","obj":"T3"},{"id":"R3","pred":"arg2Of","subj":"T4","obj":"T3"},{"id":"R4","pred":"arg1Of","subj":"T2","obj":"T5"},{"id":"R5","pred":"arg1Of","subj":"T6","obj":"T7"},{"id":"R6","pred":"arg2Of","subj":"T8","obj":"T7"},{"id":"R7","pred":"arg1Of","subj":"T7","obj":"T9"},{"id":"R8","pred":"arg2Of","subj":"T11","obj":"T9"},{"id":"R9","pred":"arg1Of","subj":"T11","obj":"T10"},{"id":"R10","pred":"arg1Of","subj":"T11","obj":"T12"},{"id":"R11","pred":"arg2Of","subj":"T15","obj":"T12"},{"id":"R12","pred":"arg1Of","subj":"T15","obj":"T13"},{"id":"R13","pred":"arg1Of","subj":"T15","obj":"T14"},{"id":"R14","pred":"arg1Of","subj":"T7","obj":"T16"},{"id":"R15","pred":"arg1Of","subj":"T17","obj":"T18"},{"id":"R16","pred":"arg2Of","subj":"T19","obj":"T18"},{"id":"R17","pred":"arg1Of","subj":"T21","obj":"T20"},{"id":"R18","pred":"arg1Of","subj":"T18","obj":"T21"},{"id":"R19","pred":"arg2Of","subj":"T22","obj":"T21"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":132,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T1","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":39},"obj":"Sentence"},{"id":"T2","span":{"begin":40,"end":114},"obj":"Sentence"},{"id":"T3","span":{"begin":115,"end":168},"obj":"Sentence"},{"id":"T4","span":{"begin":170,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVI"}